Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 11, 2012
Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)Kazuya Tsuboi, Hiroshi YamamotoBMC Pharmacology & Toxicology|June 9, 2017
Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patientsKazuya Tsuboi, Hiroshi YamamotoGenetics in Medicine : Official Journal of the American College of Medical Genetics|April 14, 2012
Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)Kazuya Tsuboi, Hiroshi YamamotoGenetics in Medicine : Official Journal of the American College of Medical Genetics|March 22, 2014
Clinical course of patients with Fabry disease who were switched from agalsidase-β to agalsidase-αKazuya Tsuboi, Hiroshi YamamotoBrain and Nerve = Shinkei Kenkyu No Shinpo|April 17, 2019
[Skin Lesion in Fabry Disease]Kazuya Tsuboi, Tamotsu KanzakiJournal of Epidemiology|July 14, 2012
Descriptive epidemiology of Fabry disease among beneficiaries of the Specified Disease Treatment Research Program in JapanKazuya Tsuboi, Sadao Suzuki, Masaki NagaiOptics Express|June 13, 2014
Laser-induced plasma generation and evolution in a transient sprayNobuyuki Kawahara, Kazuya Tsuboi, Eiji TomitaJIMD Reports|April 11, 2014
Successful management of enzyme replacement therapy in related fabry disease patients with severe adverse events by switching from agalsidase Beta (fabrazyme(®)) to agalsidase alfa (replagal (®))Kazuya Tsuboi, Hiroshi Yamamoto, Fuji Somura, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|October 5, 2018
Correlations Between Serum Cholesterol and Vascular Lesions in Fabry Disease PatientsHiroki Katsuta, Kazuya Tsuboi, Hiroshi Yamamoto, et al.Clinical and Experimental Nephrology|November 20, 2025
Detection of mulberry bodies using molecular imaging flow cytometryKazuya Tsuboi, Akinori Masago, Chiharu Asai, et al.Pageof 3